They used moderate concentrations rather than jumping to the highest available
The UK Renal Pharmacy Group emphasizes the importance of timely access to GLP-1 medications for CKD patients, including those on dialysis or post-transplant
Restarting at a high dose (like 1.0 mg or 2.0 mg) can cause severe nausea and vomiting
Not crying-we-need-to-stop this discomfort, but an Im-going-to-bite-my-lip-and-pray-this-is-over-soon discomfort
The MDL consolidates thousands of lawsuits against manufacturers such as Novo Nordisk and Eli Lilly, alleging that labels failed to adequately warn users about the risk of severe gastrointestinal side effects, including gastroparesis, ileus, and bowel obstruction
Most cases were mild to moderate side effects and tended to decrease gradually with prolonged treatment," Jiang explained